# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Lamellar ichthyosis

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 16 results.
Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine Cutaneous
Status: Unknown status
Last Changed: Oct 18, 2010
First Received: Oct 18, 2010
Disease(s): Lamellar Ichthyosis
Intervention(s): apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side, apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side
Locations: Toulouse University Hospital, Dermatology Department, Toulouse, France
A Safety, Efficacy and Systemic Exposure Study of CD5789 Cream in Adults and Adolescents With Lamellar Ichthyosis
Status: Recruiting
Last Changed: Mar 17, 2020
First Received: Nov 13, 2018
Disease(s): Lamellar Ichthyosis
Intervention(s): CD5789 Cream 200 µg/g, CD5789 Cream 100 µg/g, CD5789 Cream Vehicle
Locations: TCR Medical Corporation, San Diego, California, United States
Children's Hospital Colorado, Aurora, Colorado, United States
Yale University, New Haven, Connecticut, United States
NorthShore University HealthSystem, Skokie, Illinois, United States
Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, United States
... and 24 other locations.
A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
Status: Completed
Last Changed: Jun 19, 2019
First Received: Aug 11, 2016
Disease(s): Congenital Ichthyosis
Intervention(s): PAT-001, 0.1%, PAT-001, 0.2%, Vehicle
Locations: TCR Medical Corporation, San Diego, California, United States
Yale Center for Clinical Investigation, New Haven, Connecticut, United States
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Paddington Testing Co., Inc, Philadelphia, Pennsylvania, United States
Texas Dermatology and Laser Specialists, San Antonio, Texas, United States
... and 1 other locations.
A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis
Status: Recruiting
Last Changed: Feb 25, 2020
First Received: Nov 06, 2019
Disease(s): Congenital Ichthyosis
Intervention(s): Isotretinoin, Vehicle
Locations: Medical Dermatology Specialists, Phoenix, Arizona, United States
Stanford University School of Medicine, Palo Alto, California, United States
Austin Institute for Clinical Research, Inc, Metairie, Louisiana, United States
Dermatology Trials Australia, Kogarah, Sydney, Australia
Topical KB105 Gene Therapy for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI)
Status: Recruiting
Last Changed: Aug 29, 2019
First Received: Aug 07, 2019
Disease(s): TGM-1 Related Autosomal Recessive Congenital Ichthyosis
Intervention(s): KB105
Locations: Paddington Testing Company, Inc., Philadelphia, Pennsylvania, United States
Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar Ichthyosis
Status: Completed
Last Changed: Sep 26, 2011
First Received: Jan 27, 2006
Disease(s): Ichthyosis, Lamellar
Intervention(s): Liarozole
Locations: Academisch Ziekenhuis Vrije Universiteit Brussel, Brussels, Belgium
Geel, Geel, Belgium
Hôpital Saint-Justine, Montreal, Canada
Newlab Clinical Research Inc., St John, Canada
Instituto Dermatologico, Santo Domingo, Dominican Republic
... and 12 other locations.
A Multi-center, Prospective Evaluation of Infants and Children With Congenital Ichthyosis
Status: Recruiting
Last Changed: Jan 09, 2018
First Received: Jan 14, 2016
Disease(s): Ichthyosis
Intervention(s): Observation
Locations: Yale School of Medicine, New Haven, Connecticut, United States
Study of Scaling Disorders and Other Inherited Skin Diseases
Status: Completed
Last Changed: Mar 05, 2008
First Received: Dec 10, 2002
Disease(s): Genetic Skin Disease, Keratosis Follicularis, Lamellar Ichthyosis
Locations: National Cancer Institute (NCI), Bethesda, Maryland, United States
Phase III Study of Monolaurin Cream Therapy for Patients With Congenital Ichthyosis
Status: Completed
Last Changed: Mar 25, 2015
First Received: Feb 25, 2000
Disease(s): Ichthyosis
Intervention(s): monolaurin cream
The Efficacy and Safety of Secukinumab in Patients With Ichthyoses
Status: Active, not recruiting
Last Changed: Jul 11, 2019
First Received: Feb 02, 2017
Disease(s): Ichthyosis, Autosomal Recessive Congenital Ichthyosis, Lamellar Ichthyosis, Congenital Ichthyosiform Erythroderma, Epidermolytic Ichthyosis, Netherton Syndrome
Intervention(s): Secukinumab, Placebo
Locations: Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
Department of Dermatology Icahn School of Medicine at Mount Sinai, New York, New York, United States